Colossal Biosciences Nears Completion of Artificial Womb System
- Colossal Biosciences reports a current test success rate of 100% for its artificial womb platform.
- The remaining challenge is replicating chemical signals between early developmental stages.
- The system is not included in the company’s plans to produce a woolly mammoth by late 2028.
- Researchers have successfully guided embryos through all major developmental stages using AI and physiological monitoring.
- Colossal has expanded its reproductive engineering work across multiple species, including the birth of dire wolf pups from ancient DNA.
Colossal Biosciences has achieved a significant milestone with its artificial womb platform, reaching a full development success rate in tests while working to overcome chemical signaling challenges. The system is designed to support full gestational development outside an animal’s body, although it will not be used for their woolly mammoth project slated for late-2028 completion.
By perfecting this technology, Colossal aims to revolutionize conservation biology and reproductive medicine, potentially improving survival outcomes for endangered species through controlled ex-utero development.Source
